Log in

Relevant bibliographies by topics / Pulmonary infection / Books

To see the other types of publications on this topic, follow the link: Pulmonary infection.

Books on the topic 'Pulmonary infection'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 April 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Pulmonary infection.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Pokorski, Mieczyslaw, ed. Pulmonary Infection. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17458-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pokorski, Mieczyslaw, ed. Pulmonary Infection and Inflammation. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-44485-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Chadwick, Derek J., and Jamie Goode, eds. Innate Immunity to Pulmonary Infection. Chichester, UK: John Wiley & Sons, Ltd, 2006. http://dx.doi.org/10.1002/9780470035399.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Derek, Chadwick, Goode Jamie, and Novartis Foundation, eds. Innate immunity to pulmonary infection. Chichester: John Wiley, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Symposium on Innate Immunity to Pulmonary Infection (2005 University of Cape Town, Medical School). Innate Immunity to Pulmonary Infection. New York: John Wiley & Sons, Ltd., 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Pulmonary complications of HIV infection. Philadelphia: W.B. Saunders, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

A, White Dorothy, and Stover Diane E, eds. Pulmonary complications of HIV infection. Philadelphia: Saunders, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Agust, Carlos, and Antoni Torres, eds. Pulmonary Infection in the Immunocompromised Patient. Chichester, UK: John Wiley & Sons, Ltd, 2009. http://dx.doi.org/10.1002/9780470714171.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Carlos, Agustí, and Torres Martí A, eds. Pulmonary infection in the immuno-compromised patient: Strategies for management. Chichester, West Sussex, UK: John Wiley & Sons, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Organization), Stop TB Partnership (World Health. A revised framework to address TB-HIV co-infection in the Western Pacific Region. Geneva, Switzerland: World Health Organization, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Stop TB Partnership (World Health Organization). A revised framework to address TB-HIV co-infection in the Western Pacific Region. Geneva, Switzerland: World Health Organization, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Chmel, Herman, Mauro Bendinelli, and Herman Friedman, eds. Pulmonary Infections and Immunity. Boston, MA: Springer US, 1994. http://dx.doi.org/10.1007/978-1-4899-1063-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

1948-, Müller Nestor Luiz, Franquet Tomás, Lee Kyung Soo MD, and Silva C. Isabela S, eds. Imaging of pulmonary infections. Philadelphia: Lippincott Williams & Wilkins, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Herman, Chmel, Bendinelli Mauro, and Friedman Herman 1931-, eds. Pulmonary infections and immunity. New York: Plenum Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

F, Tenholder Michael, ed. Approach to pulmonary infections in the immunocompromised host. Mt. Kisco, NY: Futura Pub. Co., 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

1951-, Godinho Joana, ed. HIV/AIDS and tuberculosis in central Asia: Country profiles. Washington, D.C: World Bank, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Bauernfeind, Adolf, Melvin I. Marks, and Birgitta Strandvik, eds. Cystic Fibrosis Pulmonary Infections: Lessons from Around the World. Basel: Birkhäuser Basel, 1996. http://dx.doi.org/10.1007/978-3-0348-7359-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

A, Bauernfeind, Marks Melvin I, and Strandvik B, eds. Cystic fibrosis pulmonary infections: Lessons from around the world. Basel: Birkhauser Verlag, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Pulmonary effects of AIDS. Philadelphia, PA: W.B. Saunders, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

1869-1940, Abbott Maude E., ed. Patent ductus arteriosus with acute infective pulmonary endarteritis. [Philadelphia?: s.n., 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

R, Gangadharam P., ed. Mycobacteria. [S.l.]: Chapman and Hall, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Amal, Amer. Pulmonary Infection. DI Press, 2022.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

23

Amal, Amer, ed. Pulmonary Infection. InTech, 2012. http://dx.doi.org/10.5772/1494.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Pokorski, Mieczyslaw. Pulmonary Infection. Springer International Publishing AG, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Pokorski, Mieczyslaw. Pulmonary Infection. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Pokorski, Mieczyslaw. Pulmonary Infection. Springer London, Limited, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Pokorski, Mieczyslaw. Pulmonary Infection and Inflammation. Springer London, Limited, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

Pokorski, Mieczyslaw. Pulmonary Infection and Inflammation. Springer, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Pokorski, Mieczyslaw. Pulmonary Infection and Inflammation. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Goode, Jamie A., Derek J. Chadwick, and Novartis Foundation Staff. Innate Immunity to Pulmonary Infection. Wiley & Sons, Limited, John, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Foundation, Novartis. Innate Immunity to Pulmonary Infection. Wiley & Sons, Incorporated, John, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Thomas, Martin. Cytokines in Pulmonary Disease: Infection and Inflammation. Taylor & Francis Group, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

Hill, Adam T., F. X. Emmanuel, and WHB Wallace. Pulmonary Infection: An Atlas of Investigation and Management. Informa Healthcare, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Staff, Hill a. Pulmonary Infection an Atlas of Investigation and Diagnosis. Taylor & Francis Group, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

35

Foundation, Novartis. Innate Immunity to Pulmonary Infection (Novartis Foundation Symposia). Wiley, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Torres, Antoni, and Carlos Agusti. Pulmonary Infection in the Immunocompromised Patient: Strategies for Management. Wiley & Sons, Limited, John, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Torres, Antoni, and Carlos Agusti. Pulmonary Infection in the Immunocompromised Patient: Strategies for Management. Wiley & Sons, Incorporated, John, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Hansoti, Bhakti. Pulmonary Tuberculosis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0028.

Full text

Abstract:

Mycobacterium tuberculosis (TB) is most commonly known for its manifestations in the lungs; symptoms include fever and chest pain (retrosternal pain and/or dull intracapsular pain). In the reactivation stage of TB, typical symptoms may include cough, weight loss, fatigue, fever, night sweats, chest pain, dyspnea, and/or hemoptysis. Symptoms may remain undiagnosed for several years. Poverty, HIV, and drug resistance are major contributors to the resurging global TB epidemic. Two kinds of tests are used to detect TB: the tuberculin skin test or a TB blood test. These tests only tell you if a person has been infected with the bacteria. The do not differentiate between latent TB infection and active TB. This distinction clinically suspected when the clinical picture of active TB matches with initial investigations (such as acid-fast bacilli stains, chest x-ray, or CT) and is definitively confirmed by the growth of M. tuberculosis in a clinical specimen.

APA, Harvard, Vancouver, ISO, and other styles

39

Cytokines in Pulmonary Disease: Infection and Inflammation (Lung Biology in Health & Disease). Informa Healthcare, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Brill, Simon, and Jeremy Brown. Bacterial lung infection. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199657742.003.0003.

Full text

Abstract:

Bacterial lung infection may be caused by a wide variety of pathogens and may present in different ways. This chapter discusses a case presenting with signs and symptoms that were initially treated as community-acquired pneumonia, before the presence of a complicated bacterial lung abscess became clear. The clinical course was complicated by an episode of atrial fibrillation. The patient did not improve, and an underlying squamous cell carcinoma was diagnosed. The initial investigation and treatment of pneumonia are discussed, as well as risk stratification, aetiology, differential diagnosis, detailed investigations, and treatment. The potential pulmonary and cardiac complications of pneumonia are also discussed, with particular relevance to the aetiology and treatment of bacterial lung abscess. This chapter provides an overview of the varied spectrum of lung infection and reinforces the importance of considering differential diagnosis and potential complications in any patient who fails to improve with standard treatment.

APA, Harvard, Vancouver, ISO, and other styles

41

Aston, Stephen, Geraint Davies, and Nick Beeching. Mycobacterial infection other than tuberculosis. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0311.

Full text

Abstract:

Mycobacteria are aerobic bacilli with a lipid-rich cell wall and are widespread both in the environment and in animals. Many species within the genus cause disease in humans, most notably those of the Mycobacterium tuberculosis complex, which cause tuberculosis, and Mycobacterium leprae, the causative agent of leprosy. Several other species, termed non-tuberculous mycobacteria, can cause chronic cutaneous, pulmonary, and disseminated infections. This chapter will briefly review infection with non-tuberculous mycobacteria and Mycobacterium leprae.

APA, Harvard, Vancouver, ISO, and other styles

42

Sibilano, Helena. EFFECT OF UPPER RESPIRATORY INFECTION ON RESPIRATORY MUSCLE STRENGTH IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Stowell, Janet, and Ronan Breen. Pulmonary disease caused by non-tuberculous mycobacteria. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199657742.003.0014.

Full text

Abstract:

This chapter describes a case of Mycobacterium malmoense in a male ex-smoker with chronic obstructive pulmonary disease. The approaches to a diagnosis of pulmonary non-tuberculous mycobacterial disease are discussed, including key laboratory features and associated radiological changes. The factors influencing the decision to treat and treatment regimen selected are reviewed, along with evidence from landmark trials regarding drug combinations and the role of surgery in managing non-tuberculous mycobacterial disease. This case was complicated by a secondary diagnosis of invasive aspergillosis, and the challenges of treating non-tuberculous mycobacteria and Aspergillus concurrently are highlighted. Non-tuberculous mycobacterial infection in HIV-positive patients can behave differently to non-tuberculous mycobacterial disease in immunocompetent individuals. Restoring immunocompetence is key to the success of non-tuberculous mycobacterial treatment in these individuals, but beware Mycobacterium avium complex-related immune restoration inflammatory syndrome.

APA, Harvard, Vancouver, ISO, and other styles

44

Stockley, Robert. Molecular Biology of the Lung: Emphysema and Infection (Respiratory Pharmacology and Pharmacotherapy). Birkhauser, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Nosocomial Pneumonia. New York: Marcel Dekker, Inc., 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Thomas, Charles F., and Sean M. Caples. Pulmonary Infections. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199755691.003.0619.

Full text

Abstract:

Different types of infections affect the lungs. Viral infections include viral pneumonia, influenza, hantavirus, severe acute respiratory syndrome (SARS). Bacterial infections include sinusitis, otitis media, pharyngitis, bacterial pneumonia, and community-acquired pneumonia. Mycobacterial infections cause tuberculosis and nontuberculous mycobacterial disease. Fungal diseases include histoplasmosis, blastomycosis, cryptococcosis, coccidioidomycosis, and aspergillosis. Parasitic lung disease is also reviewed.

APA, Harvard, Vancouver, ISO, and other styles

47

Gupta, Nalini. Pulmonary Infections. INTECH Open Access Publisher, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Török, M. Estée, Fiona J. Cooke, and Ed Moran. Immunodeficiency and HIV. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199671328.003.0024.

Full text

Abstract:

This chapter covers primary and secondary immunodeficiency, antibody deficiency syndromes, selective T-cell deficiency, infections in asplenic patients and transplant recipients, neutropenic sepsis, HIV epidemiology, natural history, and classification, initial evaluation of the HIV patient, skin, oral, cardiovascular, neurological, and pulmonary complications, HIV gastrointestinal, liver, and kidney disease, HIV infection and malignancy, as well as HIV prevention.

APA, Harvard, Vancouver, ISO, and other styles

49

Rahimi, Rod. Atypical Pulmonary Infections. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0027.

Full text

Abstract:

Legionellosis or Legionnaires’ disease (LD) is a common cause of community-acquired pneumonia and can cause rapidly progressive respiratory failure and septic shock. Respiratory symptoms generally predominate; nonspecific symptoms include fever, malaise, myalgias, anorexia, and headache. There are no characteristic presenting clinical or radiological features, and the severity of illness can range from mild to severe. Although erythromycin was initially used to treat LD, trials have demonstrated that the newer macrolides and the respiratory fluoroquinolones are the antimicrobial agents of choice. Given the potential for outbreaks of LD, documented cases should be reported to the local or state health department. Along with LD, Legionella may cause Pontiac Fever, an influenza-like illness without pneumonia, which is self-limiting and does not require treatment.

APA, Harvard, Vancouver, ISO, and other styles

50

Tunnicliffe, Georgia, and Matthew Wise. Pulmonary fungal infections. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199657742.003.0007.

Full text

Abstract:

Pulmonary fungal infections remain relatively uncommon, although they are increasingly diagnosed as a consequence of a growing population of immunocompromised individuals, foreign travel, and improved diagnostic tools. Groups who were not previously thought to be at significant risk of invasive disease are also being recognized. The increasing incidence of fungal lung disease as a consequence of changing patient demographics means that clinicians will encounter cases in outpatient clinics, medical admission departments, and the intensive care unit with increasing frequency. As international travel increases, so too will presentations of endemic mycoses to respiratory physicians practising in the United Kingdom. Many fungi, such as Aspergillus species, are ubiquitous and can cause a spectrum of pulmonary disorders from colonization, leading to hypersensitivity reactions, to invasive disease with high mortality rates. This chapter considers commonly encountered fungi and how diseases associated with them may present.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!